Medigen

Texcell is a leading contract research organization specializing in viral testing, viral clearance, bioassays, in vivo testing, and GMP cell banking for R&D, GClP, GLP, and GMP projects. With a team of 140 employees across France, the United States, Germany, China, and Japan, Texcell serves customers worldwide and is set to expand with the inauguration of two new laboratories in 2023. Offering a range of services including cell banking, biosafety, viral clearance, and bioassays, Texcell is dedicated to supporting the growth and success of research and development projects. With a global presence and a focus on quality and innovation, Texcell is a trusted partner for organizations seeking expertise in viral testing and bioassays.Generated from the website

Veralox Therapeutics, located in Frederick, MD, is dedicated to developing innovative therapies aimed at addressing life-threatening immuno-inflammatory diseases. The company is committed to advancing its research through a robust pipeline and a talented team focused on transforming patient care. With an emphasis on a unique approach to treatment, Veralox aims to pave the way for new therapeutic options that can significantly improve outcomes for individuals affected by these challenging conditions. Their mission is rooted in the pursuit of scientific excellence and a deep understanding of the complexities of immuno-inflammatory disorders. Generated from the website